MSCs Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma
Open Access
- 10 May 2020
- preprint content
- Published by Cold Spring Harbor Laboratory
Abstract
Diffuse intrinsic pontine glioma (DIPG) is among the deadliest of pediatric brain tumors. Radiation therapy is the standard of care treatment for DIPG, but offers only transient relief of symptoms for DIPG patients without providing significant survival benefit. Oncolytic virotherapy (OV) is an anticancer treatment that has been investigated for treating various types of brain tumors. Here, we have explored the use of mesenchymal stem cells (MSC) for OV delivery and evaluated treatment efficacy using preclinical models of DIPG. Our results show that DIPG cells and tumors exhibit robust expression of cell surface proteins that are important for OV entry, and that MSCs loaded with OV disseminate within and release OV throughout the tumor in mice bearing DIPG brainstem xenografts. When combining administration of OV-loaded MSCs with radiotherapy, mice bearing brainstem DIPG xenografts experience a significant survival benefit, relative to that conferred by either therapy alone (p<0.0001). Our results support further preclinical investigation of cell-based OV therapy with radiation for potential translation in treating DIPG patients.Keywords
This publication has 56 references indexed in Scilit:
- Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG)Critical Reviews in Oncology/Hematology, 2017
- Pediatric high-grade glioma: biologically and clinically in need of new thinkingNeuro-Oncology, 2016
- Neurostimulation to improve level of consciousness in patients with epilepsyNeurosurgical Focus, 2015
- Revisiting TP53 Mutations and Immunohistochemistry—A Comparative Study in 157 Diffuse GliomasBrain Pathology, 2014
- Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypesActa Neuropathologica, 2013
- Novel Oncogenic PDGFRA Mutations in Pediatric High-Grade GliomasCancer Research, 2013
- Diffuse intrinsic pontine gliomas: A systematic update on clinical trials and biologyCancer Treatment Reviews, 2012
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomasNature Genetics, 2012
- Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult DiseaseJournal of Clinical Oncology, 2010
- Pediatric Brain Stem Tumors: Radiographic, Pathological, and Clinical CorrelationsNeurosurgery, 1983